Lydia Greenlees

598 total citations
16 papers, 480 citations indexed

About

Lydia Greenlees is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lydia Greenlees has authored 16 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Lydia Greenlees's work include Asthma and respiratory diseases (3 papers), Fibroblast Growth Factor Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Lydia Greenlees is often cited by papers focused on Asthma and respiratory diseases (3 papers), Fibroblast Growth Factor Research (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Lydia Greenlees collaborates with scholars based in United States, United Kingdom and Netherlands. Lydia Greenlees's co-authors include Katie Streicher, Koustubh Ranade, Andrew Baird, Brandon W. Higgs, Yihong Yao, Bahija Jallal, Laura K. Richman, Philip Z. Brohawn, Sharon L. Aukerman and Lois A. Chandler and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Cancer.

In The Last Decade

Lydia Greenlees

16 papers receiving 466 citations

Peers

Lydia Greenlees

MB

CR

EPIDE

ONCOL

IMMUN

Sheng‐Ben Liang Japan

Christina Sundberg Sweden

Iris Augustin Germany

Tae‐Wook Kang South Korea

Julia Etich Germany

Lindsay B. Alcaraz France

Ramon J. Whitson United States

Jonghyeob Lee United States

Fulya Taylan Sweden

Jon Cogan United States

Sheng‐Ben Liang Japan

Lydia Greenlees

421 ×1.6

MB

78 ×0.7

CR

111 ×1.5

EPIDE

185 ×2.7

ONCOL

59 ×0.9

IMMUN

Citations per year, relative to Lydia Greenlees Lydia Greenlees (= 1×) peers Sheng‐Ben Liang

Countries citing papers authored by Lydia Greenlees

Since Specialization

Citations

This map shows the geographic impact of Lydia Greenlees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lydia Greenlees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lydia Greenlees more than expected).

Fields of papers citing papers by Lydia Greenlees

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lydia Greenlees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lydia Greenlees. The network helps show where Lydia Greenlees may publish in the future.

Co-authorship network of co-authors of Lydia Greenlees

This figure shows the co-authorship network connecting the top 25 collaborators of Lydia Greenlees. A scholar is included among the top collaborators of Lydia Greenlees based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lydia Greenlees. Lydia Greenlees is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Li, Cheng, Todd Creasy, Fernanda Pilataxi, et al.. (2021). Effects of combination treatment with durvalumab plus tremelimumab on the tumor microenvironment in non-small-cell lung carcinoma. Cancer Immunology Immunotherapy. 71(5). 1167–1181. 6 indexed citations

2.

Wu, Song, et al.. (2020). Abstract 5717: LncRNA RP11-291B21.2 is associated with Durvalumab response in NSCLC and BLCA cancers. Cancer Research. 80(16_Supplement). 5717–5717. 3 indexed citations

3.

Leonard, Alexandra, Jingya Wang, Li Yu, et al.. (2019). Atopic Dermatitis Endotypes Based on Allergen Sensitization, Reactivity to Staphylococcus aureus Antigens, and Underlying Systemic Inflammation. The Journal of Allergy and Clinical Immunology In Practice. 8(1). 236–247.e3. 22 indexed citations

4.

Ascierto, Maria Libera, Yashaswi Shrestha, Qu Zhang, et al.. (2019). Abstract 3245: Durvalumab induces an NK cell response associated with clinical benefit of patients with advanced NSCLC. Cancer Research. 79(13_Supplement). 3245–3245. 1 indexed citations

5.

Hemken, Philip M., Tracey Rae, Ying Xu, et al.. (2017). Development and analytical performance of a new ARCHITECT automated dipeptidyl peptidase-4 immunoassay. Practical Laboratory Medicine. 9. 58–68. 9 indexed citations

6.

Streicher, Katie, Brandon W. Higgs, Song Wu, et al.. (2017). Increased CD73 and reduced IFNG signature expression in relation to response rates to anti-PD-1(L1) therapies in EGFR-mutant NSCLC.. Journal of Clinical Oncology. 35(15_suppl). 11505–11505. 33 indexed citations

7.

Suárez‐Fariñas, Mayte, Yeriel Estrada, Lydia Greenlees, et al.. (2017). Identification of unique proteomic signatures in allergic and non‐allergic skin disease. Clinical & Experimental Allergy. 47(11). 1456–1467. 43 indexed citations

8.

Hemken, Philip M., T. Scott Manetz, Meina Liang, et al.. (2016). Development of a new ARCHITECT automated periostin immunoassay. Clinica Chimica Acta. 464. 228–235. 10 indexed citations

9.

Liang, Meina, Ethan Grant, Katie Streicher, et al.. (2015). A new investigational use only automated immunoassay for periostin. PA3936–PA3936. 2 indexed citations

10.

Georgantas, Robert W., Katie Streicher, Xiaobing Luo, et al.. (2013). MicroRNA‐206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D. Pigment Cell & Melanoma Research. 27(2). 275–286. 61 indexed citations

11.

Georgantas, Robert W., Katie Streicher, Steven A. Greenberg, et al.. (2013). Inhibition of Myogenic MicroRNAs 1, 133, and 206 by Inflammatory Cytokines Links Inflammation and Muscle Degeneration in Adult Inflammatory Myopathies. Arthritis & Rheumatology. 66(4). 1022–1033. 116 indexed citations

12.

Zhu, Wei, Katie Streicher, Nan Shen, et al.. (2012). Genomic signatures characterize leukocyte infiltration in myositis muscles. BMC Medical Genomics. 5(1). 53–53. 32 indexed citations

13.

Gonzalez, Ana María, Martin Berry, Lydia Greenlees, Ann Logan, & Andrew Baird. (2006). Matrix‐mediated gene transfer to brain cortex and dorsal root ganglion neurones by retrograde axonal transport after dorsal column lesion. The Journal of Gene Medicine. 8(7). 901–909. 10 indexed citations

14.

Berry, Martin, Ana María Gonzalez, Lydia Greenlees, et al.. (2001). Sustained Effects of Gene-Activated Matrices after CNS Injury. Molecular and Cellular Neuroscience. 17(4). 706–716. 57 indexed citations

15.

Chandler, Lois A., Barbara A. Sosnowski, Lydia Greenlees, et al.. (1999). Prevalent expression of fibroblast growth factor (FGF) receptors and FGF2 in human tumor cell lines. International Journal of Cancer. 81(3). 451–458. 71 indexed citations

16.

Chandler, Lois A., Barbara A. Sosnowski, Lydia Greenlees, et al.. (1999). Prevalent expression of fibroblast growth factor (FGF) receptors and FGF2 in human tumor cell lines. International Journal of Cancer. 81(3). 451–458. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact